ABCB1 gene polymorphism and ABCG2 upregulation may be responsible for the resistance of NPC cancer stem cells to chemotherapeutic drugs [33, 34]; tumour suppressor gene IRF6 kills cancer stem cells in NPC by targeting the ABCG2 gene [35]. The gene discussed is ABCB1; the disease is nasopharyngeal carcinoma.